Nashville TN 心力衰竭临床试验
19项针对 心力衰竭的研究正在 Nashville及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
招募中
- St.Thomas Health, Nashville
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
招募中2 期
- Vanderbilt University Medical Center, Nashville
ELEVATE-HFpEF Clinical Study
招募中
- Saint Thomas Research Institute, Nashville
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
招募中3 期
- Research Site, Nashville
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
招募中3 期
- Vanderbilt University Medical Center, Nashville
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
招募中3 期
- Research Site, Nashville
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
招募中3 期
- Nashville, TN Investigative Site 10071, Nashville
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
招募中观察性研究
- Vanderbilt University, Nashville
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
招募中1 期
- Vanderbilt University Medical Center, Nashville
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
招募中观察性研究
- Nashville, Nashville
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
招募中观察性研究
- Tristar Centennial Medical Ctr, Nashville
- Saint Thomas Health, Nashville
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
招募中3 期
- Tenax Investigational Site, Nashville
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
招募中观察性研究
- Vanderbilt University, Nashville
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
招募中
- Vanderbilt, Nashville
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
招募中观察性研究欢迎健康志愿者
- Vanderbilt University Medical Center, Nashville
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
招募中
- Centennial Medical Center, Nashville
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
招募中
- Vanderbilt University Medical Center, Nashville
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
招募中观察性研究
- Vanderbilt University Medical Center, Nashville
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
招募中观察性研究
- Vanderbilt University Medical Center, Nashville
其他城市的 心力衰竭试验
- New York City, NY51 项研究
- Boston, MA44 项研究
- Dallas, TX42 项研究
- Houston, TX36 项研究
- Cleveland, OH33 项研究
- Chicago, IL31 项研究
- Philadelphia, PA31 项研究
- San Francisco, CA29 项研究
- Durham, NC26 项研究
- St. Louis, MO26 项研究
- Atlanta, GA25 项研究
- Kansas City, MO25 项研究
Nashville的其他研究
- 非小细胞肺癌97 项研究
- 乳腺癌81 项研究
- 转移性癌症70 项研究
- 结直肠癌69 项研究
- 癌症（所有类型）65 项研究
- 卵巢癌49 项研究
- 前列腺癌43 项研究
- 肺癌40 项研究
- 头颈鳞状细胞癌39 项研究
- 胰腺癌39 项研究
- 子宫内膜癌38 项研究
- 黑色素瘤33 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。